Abstract
FEM-PrEP was unable to determine whether once-daily, oral emtricitabine/tenofovir disoproxil fumarate reduces the risk of HIV acquisition among women because of low adherence. Self-reported adherence was high, and pill-count data suggested good adherence. Yet, drug concentrations revealed limited pill use. We conducted a follow-up study with former participants in Bondo, Kenya, and Pretoria, South Africa, to understand factors that had influenced overreporting of adherence and to learn the whereabouts of unused pills. Qualitative, semistructured interviews were conducted with 88 participants, and quantitative, audio computer-assisted self-interviews were conducted with 224 participants. We used thematic analysis and descriptive statistics to analyze the qualitative and quantitative data, respectively. In audio computer-assisted self-interviews, 31% (n = 70) said they had overreported adherence; the main reason was the belief that nonadherence would result in trial termination (69%, n = 48). A considerable percentage (35%, n = 78) acknowledged discarding unused pills. Few acknowledged giving their pills to someone else (4%, n = 10), and even fewer acknowledged giving them to someone with HIV (2%, n = 5). Many participants in the...Continue Reading
References
Aug 1, 1960·Journal of Consulting Psychology·D P CROWNE, D MARLOWE
Jan 9, 2004·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Cynthia Waszak GearyTiburce Nyama
Jun 19, 2004·BMJ : British Medical Journal·Leah Belsky, Henry S Richardson
Nov 9, 2005·The Journal of Family Planning and Reproductive Health Care·Greg GuestLawrence Adeokun
May 23, 2008·PLoS Medicine·UNKNOWN Participants in 2006 Georgetown University Workshop on Ancillary-Care Obligations of Medical Researchers Working in Developi
Apr 24, 2009·Journal of Empirical Research on Human Research Ethics : JERHRE·Kathleen M MacqueenNatasha Mack
Oct 24, 2009·Current HIV/AIDS Reports·Ira B WilsonKarina M Berg
Jul 14, 2010·AIDS and Behavior·Maria F GalloMaurizio Macaluso
Dec 6, 2011·BMC Medical Research Methodology·Alexander VuSaifuddin Ahmed
Mar 13, 2012·AIDS and Behavior·Ann Bartley WilliamsJulie A Womack
Jul 13, 2012·The New England Journal of Medicine·Jared M BaetenUNKNOWN Partners PrEP Study Team
Jul 13, 2012·The New England Journal of Medicine·Lut Van DammeUNKNOWN FEM-PrEP Study Group
Feb 26, 2013·AIDS and Behavior·K Rivet AmicoAriane van der Straten
Sep 24, 2013·PLoS Medicine·Jessica E HabererDavid R Bangsberg
May 3, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Deborah DonnellConnie Celum
Aug 27, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Amy L CorneliUNKNOWN FEM-PrEP Study Group
Oct 18, 2014·Science·Kelly Servick
Sep 1, 2006·African Journal of AIDS Research : AJAR·Kata ChillagDawn K Smith
Citations
Oct 21, 2015·Anthropology & Medicine·Patricia Kingori
Apr 14, 2015·PloS One·Amy CorneliLut Van Damme
Mar 16, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kerry A ThomsonUNKNOWN Partners PrEP Study Team
Mar 10, 2016·Journal of Empirical Research on Human Research Ethics : JERHRE·Celia B FisherBrian Mustanski
Jun 1, 2018·Journal of the International AIDS Society·Norma C WareElly T Katabira
Mar 20, 2016·AIDS and Behavior·K Rivet AmicoUNKNOWN iPrEx Study Team
Sep 16, 2018·AIDS and Behavior·Barbara S MenschUNKNOWN MTN-020/ASPIRE study team
Mar 15, 2019·Journal of the International AIDS Society·K Rivet AmicoUNKNOWN HPTN 069/A5305 Study Team and HPTN Women at Risk Committee
Mar 14, 2019·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Monica GandhiMaria L Ekstrand
Oct 21, 2016·AIDS and Behavior·Barbara S MenschAriane van der Straten
Jul 23, 2019·Journal of the International AIDS Society·Connie L CelumLinda-Gail Bekker
Jul 23, 2019·Journal of the International AIDS Society·Robyn EakleAdam Bourne
Dec 4, 2015·Current Opinion in HIV and AIDS·Jessica E Haberer
Sep 30, 2015·Current Opinion in HIV and AIDS·Kerry A ThomsonRenee Heffron
Jul 23, 2015·Journal of the International AIDS Society·Connie L CelumJared M Baeten
Jul 23, 2015·Journal of the International AIDS Society·Carlos F CáceresKevin R O'Reilly
Apr 3, 2020·JMIR Research Protocols·Paul DrainMonica Gandhi
Nov 20, 2016·AIDS and Behavior·Elizabeth T MontgomeryA van der Straten
Jan 23, 2019·AIDS and Behavior·Jane M SimoniBarbara S Mensch
Feb 7, 2016·Journal of the International AIDS Society·Ariane van der StratenUNKNOWN MTN-003 VOICE Protocol Team for Microbicide Trials Network
Nov 5, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Amy CorneliLut Van Damme
Aug 10, 2016·AIDS and Behavior·Julie H Levison, Margarita Alegría
Dec 14, 2018·AIDS and Behavior·Stefanie J VaccherUNKNOWN NSW HIV Prevention Partnership Project
May 20, 2020·Current HIV/AIDS Reports·Matthew A SpinelliMonica Gandhi
Jan 23, 2017·AIDS and Behavior·Petina MusaraUNKNOWN Microbicide Trials Network-003D Study Team
Jun 19, 2016·AIDS and Behavior·K Rivet AmicoRobert M Grant
Sep 12, 2020·AIDS Research and Therapy·Kennedy Michael NgowiI Marion Sumari-de Boer
Nov 7, 2015·AIDS·Ariane van der StratenUNKNOWN Microbicide Trials Network-003D Study Team
May 21, 2018·AIDS and Behavior·Alyssa C MooneySheri A Lippman
Jan 8, 2021·PloS One·Lori MillerRichard Hayes
Dec 5, 2020·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jillian PintyeKristin Beima-Sofie
Mar 18, 2021·Patient Preference and Adherence·Kennedy NgowiMarion Sumari-de Boer
Apr 7, 2021·BMJ Open·David S LawrenceJanet Seeley
May 28, 2021·PloS One·Seth ZissetteGustavo F Doncel
Jun 19, 2021·PLoS Medicine·Connie CelumSinead Delany-Moretlwe